DAPTOMYCIN Accord subst seche 350 mg 1 pce

7680672730011 CH-67273 J01XX09 08.01.9.

Active substances:

DAPTOMYCIN Accord subst seche 350 mg 1 pce
DAPTOMYCIN Accord subst seche 350 mg 1 pce
DAPTOMYCIN Accord subst seche 350 mg 1 pce
1 / 3
google

Details

Product number
6727301
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: daptomycinum 350 mg, natrii hydroxidum corresp. natrium 11 mg, pro vitro.

Articles (1)

Daptomycin Accord 350 mg, Pulver zur Herstellung einer Infusions-/Injektionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/10/2023
Professional SmPC
Français
17/10/2023
Professional SmPC
Italien
17/10/2023

Detailed composition

Substance Quantity Type Category
daptomycinum
350.0 MG Substance Wirkstoff (Principe actif)
natrii hydroxidum
- Substance HNIDK
natrium
11.0 MG Substance HBESI

Reimbursement information

Public price
CHF 92.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2020

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67273
Drug name
Daptomycin Accord, Pulver zur Herstellung einer Infusions-/Injektionslösung
Galenic form
PULP
ATC Code
J01XX09
Authorization status
Z
Dispensation category
A
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT number
08.01.9.
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
DAPTOMYCIN Accord subst seche 350 mg 1 pce
Description (DE)
DAPTOMYCIN Accord Trockensub 350 mg 1 Stk
Market launch
13/02/2020
Narcotic (BTM)
No

Original drug

Cubicin, Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 104.60
View original

Other packaging sizes

DAPTOMYCIN Accord subst seche 500 mg 1 pce
1 DUR
View
Buy us a coffee Explore the data